A meta‐analysis including 12 993 patients pointed out that elevated serum CA153 or CEA was associated with poor disease‐free survival and overall survival in breast cancer.5 In recent years, a number of studies have focused on the association of serum tumor markers and clinicopathological features, but inconsistent results were reported. Here, CEACAM5 is linked to breast cancer.